此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

使用人工智能听诊器进行三重心血管疾病检测 (TRICORDER)

2026年11月5日 更新者:Imperial College London

Heart failure (HF) is a condition in which the heart cannot pump blood adequately. It is increasingly common, consumes 4% of the UK National Health Service (NHS) budget and is deadlier than most cancers. Early diagnosis and treatment of HF improves quality of life and survival. Unacceptably, 80% of patients have their HF diagnosed only when very unwell, requiring an emergency hospital admission, with worse survival and higher treatment costs to the NHS. This is largely because General Practitioners (GPs) have no easy-to-use tools to check for suspected HF, with patients having to rely on a long and rarely completed diagnostic pathway involving blood tests and hospital assessment.

The investigators have previously demonstrated that an artificial intelligence-enabled stethoscope (AI-stethoscope) can detect HF in 15 seconds with 92% accuracy (regardless of age, gender or ethnicity) - even before patients develop symptoms. While the GP uses the stethoscope, it records the heart sounds and electrical activity, and uses inbuilt artificial intelligence to detect HF.

The goal of this clinical trial is to determine the clinical and cost-effectiveness of providing primary care teams with the AI-stethoscope for the detection of heart failure. The main questions it aims to answer are if provision of the AI-stethoscope:

  1. Increases overall detection of heart failure
  2. Reduces the proportion of patients being diagnosed with heart failure following an emergency hospital admission
  3. Reduces healthcare system costs

200 primary care practices across North West London and North Wales, UK, will be recruited to a cluster randomised controlled trial, meaning half of the primary care practices will be randomly assigned to have AI-stethoscopes for use in direct clinical care, and half will not. Researchers will compare clinical and cost outcomes between the groups.

研究概览

详细说明

Triple Cardiovascular Disease Detection with Artificial Intelligence-enabled Stethoscope (TRICORDER) is an open label, cluster randomised controlled trial. The aim is to determine whether use of an artificial intelligence-enabled stethoscope (AI-stethoscope) in UK Primary Care improves community-based detection of heart failure (HF), compared with usual care. 200 primary care practices in North West London (UK) will be randomised to receive the AI-stethoscope (intervention arm) or continue with usual care (control arm). The intervention arm will use the AI-stethoscope in routine clinical practice. Outcomes will be measured using pooled primary and secondary care clinical and cost-data, as well as clinician questionnaires.

研究类型

介入性

注册 (实际的)

200

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • London、英国
        • NHS North West London Integrated Care System

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Primary care practices that care for adult patients and have the ability to request natriuretic peptide blood testing
  • Primary care practices within the NIHR North West London Clinical Research Network or Betsi Cadwaladr University Health Board.

Exclusion Criteria:

  • Poor WiFi and/or mobile data connectivity within primary care consulting rooms
  • No face-to-face patient consultations

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:诊断
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
无干预:Control

Usual care

实验性的:Intervention

Receive 3-6 AI-stethoscopes (Eko DUO, Eko Health Inc, CA, USA) including artificial intelligence software for detection of:

  1. Reduced left ventricular ejection fraction <40%
  2. Atrial fibrillation
  3. Cardiac murmurs

Clinicians at practices in the intervention arm will be provided with one session of in-person training in use of the AI-stethoscope within 2 weeks of randomisation, including

  1. Delivery and setup
  2. Smartphone app installation and login
  3. Pairing of all clinician smartphones with all AI-stethoscopes in the same practice
  4. Demo of patient examination The AI-stethoscope will be used within its CE/UKCA-marked intended purpose. The clinical guidelines for use have been agreed by the NHS North West London Integrated Care System and Betsi Cadwaladr University Health Board Cardiovascular Executive Groups. Patients will be examined with the AI-stethoscope in accordance with these guidelines, and/or where stethoscope examination is deemed clinically appropriate. Patients will provide verbal consent for examination with the AI-stethoscope as per any physical examination performed by healthcare professionals for direct care, in accordance with UK law and General Medical Council guidelines.
其他名称:
  • 埃科二人组
  • Eko核心500
  • 埃科EAS

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Incidence of heart failure (co-primary)
大体时间:24 months

Difference in incidence of coded new diagnoses of heart failure (HF)

24 months
Ratio of route to diagnosis of heart failure (co-primary) between emergency and community-based pathways
大体时间:24 months

Difference in ratio of the incidence of coded diagnoses of HF via hospital admission-based versus community-based pathways.

24 months

次要结果测量

结果测量
措施说明
大体时间
Incidence of atrial fibrillation
大体时间:24 months

New coded diagnoses of atrial fibrillation (AF)

24 months
Incidence of valvular heart disease
大体时间:24 months

New coded diagnoses of valvular heart disease (VHD)

24 months
Cost-consequence (AF)
大体时间:24 months

Cost-consequence analysis (form of health economic evaluation) for diagnosis of atrial fibrillation, stratified by route to diagnosis. Presented in pounds sterling.

24 months
Cost-consequence (HFrEF)
大体时间:24 months

Cost-consequence analysis (form of health economic evaluation) for diagnosis of HFrEF, stratified by route to diagnosis. Presented in pounds sterling.

24 months
Cost-consequence (VHD)
大体时间:24 months

Cost-consequence analysis (form of health economic evaluation) for diagnosis of VHD, stratified by route to diagnosis. Presented in pounds sterling.

24 months
Health service utilisation
大体时间:24 months

Health service utilisation for diagnostics e.g. rates of request for echocardiography, electrocardiography, primary care appointments. Collected from NHS organisation business intelligence repositories and UK Trusted Research Environments.

24 months
Proportion of patients prescribed guideline-directed medical therapy
大体时间:24 months

Proportion of patients prescribedguideline-directed medical therapy (HF, AF, VHD)

24 months
Device therapy
大体时间:24 months

New implantation of cardiac resynchronisation therapy (CRT) and/or implantable cardioverter-defibrillator (ICD)

24 months
Uptake and utilisation
大体时间:24 months

Differential rates of uptake and utilisation of AI-stethoscope in primary care

24 months
Determinants of uptake and utilisation
大体时间:24 months

Determinants of utilisation of AI-stethoscope in primary care (clinician questionnaires)

24 months
Patient quality of life
大体时间:24 months

Healthy Days at Home (patient-level analysis)

24 months

其他结果措施

结果测量
措施说明
大体时间
Sensitivity analysis
大体时间:24 months

Patient-level sensitivity analyses will be performed for patients with abnormal Eko DUO predictions for HF, to identify direct associations between AI-stethoscope predictions and specific diagnostic codes for HF, AF and VHD

24 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Nicholas S Peters, MD、Imperial College London

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2023年10月25日

初级完成 (估计的)

2028年6月23日

研究完成 (估计的)

2028年6月23日

研究注册日期

首次提交

2023年7月21日

首先提交符合 QC 标准的

2023年8月4日

首次发布 (实际的)

2023年8月14日

研究记录更新

最后更新发布 (实际的)

2026年11月10日

上次提交的符合 QC 标准的更新

2026年11月5日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

是的

在美国制造并从美国出口的产品

是的

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅